Published online Mar 24, 2015. doi: 10.5410/wjcu.v4.i1.21
Peer-review started: May 23, 2014
First decision: July 18, 2014
Revised: January 12, 2015
Accepted: February 4, 2015
Article in press: February 9, 2015
Published online: March 24, 2015
Processing time: 306 Days and 6.5 Hours
Prostate cancer is the most common neoplasm diagnosed in men. Whilst treatment modalities have progressed, diagnostic investigations in terms of biopsy methods have been assessed but there is no consensus of when the different diagnostic methods in terms of transrectal ultrasound (TRUS) or transperineal template (TPT) should be utilised. TPT biopsy has a higher diagnostic yield than TRUS in those with a primary biopsy, in those with previous negative biopsies with TRUS as well as those undergoing saturation biopsies. Despite the increased likelihood of diagnosing cancer with TPT than TRUS this maybe secondary to the increased number of biopsies being utilised. However there is no consensus regarding the ideal number of biopsies that should be utilised with TPT. Furthermore it is felt that the increased number of biopsies utilised with TPT is associated the higher complication rates with TPT. The role of TPT biopsy is recognised in those with previous negative biopsies with transrectal ultrasound but further work is required regarding the ideal number of biopsies. Furthermore, it is felt that TPT biopsy may have a role in primary biopsy.
Core tip: Transperineal template biopsies are utilised in prostate cancer at an increasing rate instead of transrectal biopsies, yet there is no consensus on how this investigation should be utilised. Here we assess when this method of prostate biopsy is utilised, the number of biopsies that are taken and the method of transperineal template biopsy as well the likelihood of the increase in accuracy in diagnosing prostate cancer.